Medpace Holdings, Inc. (MEDP) Stock Analysis
A live, multi-source view of Medpace Holdings, Inc. (MEDP): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Sector: Healthcare · Industry: Diagnostics & Research · United States · 6,500 employees · medpace.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Medpace Holdings, Inc. (MEDP) had a market capitalization of $16.50B, a trailing P/E of 34.7 (forward 30.6) and a beta of 1.15; the shares traded in a 52-week range of $373.00 – $677.90 (20.2% over the year).
- Market cap
- $16.50B
- Enterprise value
- $16.15B
- Trailing P/E
- 34.7
- Forward P/E
- 30.6
- PEG ratio
- 2.77
- Price / book
- 38.04
- EPS (trailing)
- $17.03
- EPS (forward)
- $19.31
- Payout ratio
- 0.0%
- 52-week range
- $373.00 – $677.90
- 52-week change
- 20.2%
- Beta
- 1.15
- Average volume
- 299,111
- Shares outstanding
- 27.9M
- Short % of float
- 7.06%
- Profit margin
- 17.7%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Medpace Holdings, Inc. (MEDP) last closed at $583.16 (the last completed close before that scan).
Technicals at the scan: RSI 46 (neutral territory), price -2.6% versus its 20-day average, 20-day versus 50-day average spread +3.6%, MACD histogram -4.68.
Sentiment inputs: StockTwits 71% bullish; analyst consensus score 54/100.
Next scheduled company event: in 38 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of MEDP; corporate insiders filed 0 buys and 20 sells (7 distinct filers, latest disclosure 2026-08-31). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: August J. Troendle (0B/13S), Cornelius P. Mccarthy III (0B/2S), Robert O. Kraft (0B/1S), Kevin M. Brady (0B/1S), Brian T. Carley (0B/1S), Fred B. Davenport Jr. (0B/1S). Who is trading what
RapidTradeView pick record
MEDP has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Medpace Holdings, Inc. (MEDP) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell MEDP.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.